The abnormal activation of the oncogenic phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling is associated with HCC, drives cell survival and proliferation [13]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.